Successful use of nafcillin and ceftaroline combination therapy for persistent MSSA bacteraemia and endocarditis: a case series

Erin F Warren¹, R Jake Crocker¹, Benjamin Tabor¹, Morgan Pizzuti¹, Y Vivian Tsai¹, Kayla Antosz^{1

2}, Sarah Battle^{3

4}, Divya Ahuja^{3

4}, P Brandon Bookstaver^{1

2}

Affiliations

¹ Department of Pharmacy, Prisma Health Richland, 5 Richland Medical Park Drive, Columbia 29203, SC, USA.
² Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, 715 Sumter Street, Columbia 29208, SC, USA.
³ Department of Internal Medicine, University of South Carolina School of Medicine, 6311 Garners Ferry Road, Columbia 29209, SC, USA.
⁴ Department of Medicine, Division of Infectious Diseases, Prisma Health-University of South Carolina Medical Group, 1 Richland Medical Park Drive, Suite # 420, Columbia 29203, SC, USA.

Erin F Warren et al. JAC Antimicrob Resist. 2022.

. 2022 Dec 29;5(1):dlac129.

doi: 10.1093/jacamr/dlac129. eCollection 2023 Feb.

Erin F Warren¹, R Jake Crocker¹, Benjamin Tabor¹, Morgan Pizzuti¹, Y Vivian Tsai¹, Kayla Antosz^{1

2}, Sarah Battle^{3

4}, Divya Ahuja^{3

4}, P Brandon Bookstaver^{1

2}

¹ Department of Pharmacy, Prisma Health Richland, 5 Richland Medical Park Drive, Columbia 29203, SC, USA.
² Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, 715 Sumter Street, Columbia 29208, SC, USA.
³ Department of Internal Medicine, University of South Carolina School of Medicine, 6311 Garners Ferry Road, Columbia 29209, SC, USA.
⁴ Department of Medicine, Division of Infectious Diseases, Prisma Health-University of South Carolina Medical Group, 1 Richland Medical Park Drive, Suite # 420, Columbia 29203, SC, USA.

No abstract available

References

1. Kourtis A, Hatfield K, Baggs J et al. Vital signs: epidemiology and recent trends in methicillin- resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States. MMWR 2019; 68: 214–9. 10.15585/mmwr.mm6809e1 - DOI - PMC - PubMed
1. McDanel JS, Roghmann MC, Perencevich EN et al. Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study. Clin Infect Dis 2017; 65: 100–6. 10.1093/cid/cix287 - DOI - PubMed
1. Sakoulas G, Olson J, Yim J et al. Cefazolin and ertapenem, a synergistic combination used to clear persistent Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2016; 60: 6609–18. 10.1128/AAC.01192-16 - DOI - PMC - PubMed
1. Moisan H, Pruneau M, Malouin F. Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae. J Antimicrob Chemother 2010; 65: 713–6. 10.1093/jac/dkp503 - DOI - PubMed
1. Sader HS, Farrell DJ, Flamm RK et al. Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009–13). J Antimicrob Chemother 2015; 70: 2053–6. 10.1093/jac/dkv076 - DOI - PubMed